Zecotek Grants Manufacturing Contract to Anteryon BV for Key Component of its 3D Display.
Vancouver, July 26, 2007 - Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that it has it has selected Anteryon BV of the Netherlands to produce the key screen component of its proprietary Real-Time 3D / 2D Display. Anteryon will produce Zecotek’s proprietary 3D lenticular display in a 32″ screen format, considered the optimum size to demonstrate its potential power and user impact. The first demonstration model is expected to be delivered in October this year and will be used for marketing and sales purposes including demonstrations at upcoming industry tradeshows.
“We are extremely pleased that Zecotek has selected Anteryon as its 3D display production partner,” said Geoff Bertenshaw, Chief Executive Officer of Anteryon. “We recognize the unique and cutting edge technology of Zecotek’s 3D display technology and we see it as a truly breakthrough product having a very large market potential.”
“Anteryon is an industry leader recognized for its product performance and its innovative approach to manufacturing high precision optical products,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Medical Systems. “Our partnership with Anteryon is an important strategic milestone in the development of Real-Time 3D / 2D Display. After initial production we look forward to establishing a strategic joint venture for future mass production of our 3D / 2D display.”
In March 2007, Zecotek announced that it has signed a letter of intent (LOI) with a Japanese electronics major for its Real-Time 3D / 2D Display. The LOI calls for both parties to lay the groundwork for a joint relationship whereby Zecotek and the company would collaborate on an ongoing basis in the final assembly and commercialization of the 3D / 2D Display. Under such arrangement, Anteryon BV will continue to manufacture the key screen component for the Real-Time 3D / 2D Display. Zecotek continues to work toward creating a strategic relationship with the Japanese electronics major in preparation of mass production of the Real-Time 3D / 2D Display. Under the LOI, the identity of the company remains confidential pending terms of an agreement.
Zecotek’s Real-Time 3D2D Display System is a novel, proprietary, real-time display system for the visualization of images and data. Based on the auto-stereoscopic principle, but with substantial innovative and patented improvements, it represents a new generation of 3D displays. The system is aimed at meeting all of the criteria for both mass market and professional desktop use. Its design provides for multi-user, multi-view, freedom of movement, high resolution in both 3D and 2D mode (Higher than 1024×768), superior image dynamic range in 2D mode, 3D and 2D simultaneously, with common brightness, and importantly compatibility with existing applications.
With its high resolution and unique technology, Zecotek’s 2D / 3D display has attracted strong interest from a variety of end users for applications in bio-medical imaging, medical training, graphic design, advertising, education and entertainment. A 17″ design is also being developed for desktop, medical and industrial training applications. The integration of the screen and final assembly will take place in Zecotek’s Vancouver and Singapore facilities.
– 30 –
Anteryon BV is Netherlands based company which provides innovative high-tech optical solutions from component to product level. Its cluster of three technologies; glass machining, replication of optical structures and opto mechanical assembly, provides the platform for the highest product performance delivered fast and with full attention to customer development demands. It provides specific optics solutions in Industrial, Imaging and Display and in Data & Telecom markets and is also active in the emerging bio-photonics market. Anteryon has a strong track record of innovation across a range of optical markets coupled to a blue ribbon customer listing, testimony to the capability of the company from prototype to volume production. More about the company can be found at www.anteryon.com.
Zecotek Medical Systems (TSX-V: ZMS; Frankfurt: W1I.F) is a bio-photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: medical imaging, medical lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For additional information on Zecotek Medical Systems and our technologies please see our website at Zecotek Photonics.
For additional information please contact:
CFO; VP Corporate Development
T: (604) 827-5203
Caliber Capital Partners
T: (778) 327-6678
E: [email protected]
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at Zecotek Photonics.